<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01798381</url>
  </required_header>
  <id_info>
    <org_study_id>OCEAN-GER</org_study_id>
    <nct_id>NCT01798381</nct_id>
  </id_info>
  <brief_title>Essential Fatty Acids in Adult ADHD</brief_title>
  <acronym>OCEAN-GER</acronym>
  <official_title>The Relationship of Essential Fatty Acids to Cognitive, Electrophysiological and Behavioural Function in Adults With Attention Deficit Hyperactivity Disorder and Controls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universität des Saarlandes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universität des Saarlandes</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this project is to investigate the effect of a dietary supplementation with&#xD;
      essential fatty acids in adults on cognitive functions related to attention and impulse&#xD;
      control in the general population and in individuals with a diagnosis of attention deficit&#xD;
      hyperactivity disorder (ADHD).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wender Reimherr Adult Attention Deficit Disorder Scale (WRAADDS)</measure>
    <time_frame>6 months</time_frame>
    <description>Psychopatholoy of adult ADHD</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short and long interval cortical inhibition (SICI and LICI)</measure>
    <time_frame>6 months</time_frame>
    <description>Motoric evoced potentials by transcranial magnetic stimulation (TMS)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cued continous performance test - QB-version</measure>
    <time_frame>6 months</time_frame>
    <description>Motorhyper activity, concentration and impulsivity in adult ADHD patients</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Adult Attention Deficit Hyperactivity Disorder</condition>
  <arm_group>
    <arm_group_label>Essential fatty acids</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Omega-3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo tablet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Essential fatty acids</intervention_name>
    <arm_group_label>Essential fatty acids</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  DSM-IV ADHD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  any acute psychiatric disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Saarland University Hospital</name>
      <address>
        <city>Homburg/Saar</city>
        <state>Saarland</state>
        <zip>D-66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>February 19, 2013</study_first_submitted>
  <study_first_submitted_qc>February 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2013</study_first_posted>
  <last_update_submitted>October 27, 2020</last_update_submitted>
  <last_update_submitted_qc>October 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universität des Saarlandes</investigator_affiliation>
    <investigator_full_name>Michael Rösler</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

